Inhibiting MEK has shown in suppressing lung cell proliferation induced by TGF-α, reducing the expression of matrix genes in vivo, thus preventing TGF-α-induced pulmonary fibrosis, and halting the progression of established pulmonary fibrosis [81]. Here, MAP2K7 is linked to pulmonary fibrosis.